{"cik":"0001800315","ticker":"DMRA","name":"Damora Therapeutics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-05-08","last_filing_date":"2026-05-12","url":"/sec/cik-0001800315","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-219327","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-12","title":"10-Q — Damora Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001800315/10-q/0001193125-26-219327","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800315/0001193125-26-219327-index.html"},{"accession_number":"0001193125-26-214909","form_type":"3","form_type_family":"insider","doc_date":"2026-05-08","title":"3 — Damora Therapeutics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001800315/3/0001193125-26-214909","edgar_url":"https://www.sec.gov/Archives/edgar/data/1800315/0001193125-26-214909-index.html"}],"related_endpoints":{"profile":"/sec/DMRA/profile","timeline":"/sec/DMRA/timeline","peers":"/sec/DMRA/peers","insider_pulse":"/sec/DMRA/insider-pulse","insider_summary":"/sec/DMRA/insider-summary","insider_transactions":"/sec/DMRA/insider-transactions","form144":"/sec/DMRA/form144","holdings_as_filer":"/sec/DMRA/holdings","financial_facts":"/sec/DMRA/financial-facts","derivatives":"/sec/DMRA/derivatives","officers":"/sec/DMRA/officers","insider_network":"/sec/DMRA/insider-network","risk_flags":"/sec/DMRA/risk-flags","filings":"/sec/DMRA/filings","cross_topic_dossier":"/api/v1/dossier?ticker=DMRA"}}